Form 4 for ACIU AC Immune SA
Accepted 2026-04-16 11:10:49 ET · period of report 2026-04-15 · accession 0001651625-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-16 11:10 | 2026-04-15 | ACIU | Pfeifer Andrea | CEO, Dir | P - Purchase | $3.14 | -10.0K | 3.83M | -0.3% | -$31.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Share | 2026-04-15 | P | D | 10,000 | $3.14 | 3,830,288 | D | — | — | (F2) The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.05 to $3.19, inclusive. (F1) Includes 1,921,005 common shares underlying outstanding restricted share units. |